Short Interest in Venus Concept Inc. (NASDAQ:VERO) Decreases By 99.2%

Venus Concept Inc. (NASDAQ:VERO) saw a large decline in short interest in February. As of February 15th, there was short interest totalling 600 shares, a decline of 99.2% from the January 31st total of 73,100 shares. Based on an average trading volume of 544,000 shares, the days-to-cover ratio is presently 0.0 days. Approximately 0.0% of the shares of the stock are short sold.

Venus Concept Price Performance

Shares of NASDAQ VERO opened at $0.29 on Friday. The firm has a market cap of $2.12 million, a PE ratio of -0.04 and a beta of 0.51. The firm has a fifty day moving average of $0.36 and a 200 day moving average of $0.43. The company has a debt-to-equity ratio of 2.83, a quick ratio of 1.18 and a current ratio of 1.86. Venus Concept has a one year low of $0.28 and a one year high of $1.59.

Venus Concept shares are going to reverse split on Tuesday, March 4th. The 1-11 reverse split was announced on Friday, February 14th. The number of shares owned by shareholders will be adjusted after the closing bell on Monday, March 3rd.

Venus Concept Company Profile

Venus Concept Inc, a medical technology company, develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies, and related services in the United States and internationally. Its product portfolio includes Venus Legacy, a noninvasive device used in dermatological and general surgical procedures for females; Venus Versa, a multi-application device used in aesthetic and cosmetic procedures; Venus Versa Pro; and Venus Viva and Venus Viva MD, an advanced, portable, and fractional RF system for dermatological procedures requiring ablation and resurfacing of the skin.